Profil
An Song currently works at 4D Molecular Therapeutics, Inc., as Chief Research & Translational Development Officer from 2024.
Dr. Song also formerly worked at Immune-Onc Therapeutics, Inc., as Chief Scientific Officer.
Dr. Song received her doctorate degree from Indiana University.
Aktiva positioner av An Song
| Företag | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-09-25 |
Tidigare kända positioner av An Song
| Företag | Position | Slut |
|---|---|---|
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2018-07-01 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2002-08-01 |
An Songs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Health Technology |
















